On March 10, 2023, Unique Logistics International, Inc. entered into a financing agreement as borrower with certain of its subsidiaries party thereto as guarantors (collectively, "the Borrowers"), the lenders party thereto CB Agent Services LLC, as origination agent (CB Agent"), and Alter Domus (US) LLC, as collateral agent and administrative agent for an initial senior secured term loan in a principal amount of $4,210,526.32 and a delayed draft term loan in an aggregate principal amount of up to $14,789,473.68. Capitalized terms used but not otherwise defined herein have the same definitions given to such terms in the Agreement. Effective March 1, 2024, the Parties entered into a waiver and amendment no.

2 to financing agreement, whereby the Agents and the Lenders agreed to waive that certain Event of Default that has occurred or may occur, due to the Loan Parties' noncompliance with Section 7.03 of the Agreement for each of the fiscal quarters in the fiscal year ending May 31, 2024 and for the fiscal quarter ending August 31, 2024 that certain Event of Default that has occurred or may occur, due to the Loan Parties' noncompliance with Section 7.03(b) of the Agreement for each of the fiscal quarters in the fiscal year ending May 31, 2024 and for the fiscal quarter ending August 31, 2024 and that certain Event of Default that has occurred or may occur, due to the Loan Parties' noncompliance with Section 7.03(c) of the Agreement for each of the fiscal quarters in the fiscal year ending May 31, 2024 and for the fiscal quarter ending August 31, 2024. Each of the Specified Events of Default constitute an Event of Default under Section 9.01(c) of the Agreement; and interest at the Post-Default Rate with respect to the Specified Events of Default from the date such event occurred through the Waiver and Second Amendment Effective Date. In addition, pursuant to the Second Waiver, the Borrowers agreed to (i) pay the administrative agent a non-refundable Waiver Fee in an aggregate amount equal to $3,000,000, which was deemed fully earned on the Effective Date; and (ii) issue the origination agent or its designee warrants, in form and substance satisfactory to the origination agent, entitling the holder thereof to purchase a number of shares of the Company's common stock equal to the greater of (a) 7% of enterprise value (as calculated in a manner to be mutually agreed and acceptable to the origination agent and the Company on a fully diluted basis and (b) $7,000,000, on terms, conditions and in a form reasonably acceptable to origination agent, and having an exercise price of $0.01 per share.